US Biotech Sector Sees Broad Early Declines as Eli Lilly Falls 1.29%, Johnson & Johnson Drops 1.06%

Deep News11-17 22:53

On November 17, the US biotech sector experienced broad declines in early trading.

Eli Lilly fell 1.29%, while Johnson & Johnson dropped 1.06%. Moderna declined 1.93%, and Novo Nordisk slid 1.75%.

AbbVie was down 0.78%, and Merck & Co. decreased 0.82%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment